Trial reportEuropean journal of physical and rehabilitation medicine2026
Clinical outcomes of rehabilitation with a robotic anthropomorphic exoskeleton in patients with motor-incomplete spinal cord injury: a multicenter randomized controlled trial.
Trial report in European journal of physical and rehabilitation medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- The evidence landscape, clinical role, and mechanisms of action of robot-assisted injury treatment: a systematic review.Journal of robotic surgery · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRobotic exoskeletons offer a promising tool for gait rehabilitation in individuals with spinal cord injury (SCI). However, evidence of their additive benefit over conventional therapy, particularly in non-acute, motor-incomplete SCI, remains limited.
aimTo evaluate the efficacy of the EKSO-GT
designRandomized, controlled, multicenter trial.
settingRehabilitation centers.
methodsThirty-six patients with chronic, motor-incomplete SCI (AIS C/D, 1-5 years post-injury) were randomized to receive either 4 weeks of exoskeleton-assisted training followed by 4 weeks of standard rehabilitation (RC+E), or 8 weeks of standard rehabilitation alone (RC). The primary outcome was the proportion of participants achieving ≥ 10% improvement in walking speed (10-meter walk test) at 4 weeks. Secondary outcomes included gait endurance, muscle strength, spasticity, proprioception, pain and mood.
resultsAt 4 weeks, 33.3% of RC+E vs. 46.7% of RC patients improved in walking speed (P=0.44); at 8 weeks, 43.8% vs. 66.7%, respectively (P=0.20). No significant between-group differences were found for any outcome, including endurance, strength, or pain. Both groups demonstrated clinically relevant within-group improvements over time. No adverse events occurred.
conclusionsIn individuals with chronic, motor-incomplete SCI, robotic gait training using the EKSO-GT CLINICAL REHABILITATION IMPACT: While robotic exoskeletons are feasible and safe in chronic SCI rehabilitation, their routine use as a short-term add-on to standard therapy may not yield additional functional benefits under the tested conditions. Emphasis should remain on comprehensive, individualized rehabilitation programs tailored to patient-specific needs. Larger, adequately powered studies are needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.